These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21974896)
1. Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome. Heinzelbecker J; Kempf KM; Kurz K; Steidler A; Weiss C; Jackson DG; Bolenz C; Haecker A; Trojan L Urol Oncol; 2013 Oct; 31(7):1386-94. PubMed ID: 21974896 [TBL] [Abstract][Full Text] [Related]
2. The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors. Heinzelbecker J; Gropp T; Weiss C; Huettl K; Stroebel P; Haecker A; Bolenz C; Trojan L Urol Oncol; 2014 Feb; 32(2):178-85. PubMed ID: 23141777 [TBL] [Abstract][Full Text] [Related]
3. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575 [TBL] [Abstract][Full Text] [Related]
4. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. Wang XL; Fang JP; Tang RY; Chen XM BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772 [TBL] [Abstract][Full Text] [Related]
5. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer. Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer. Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715 [TBL] [Abstract][Full Text] [Related]
9. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma]. Zou JD; Fu HY; Xu W; Lü ZH; Cao HY; Luan XY Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):461-4. PubMed ID: 21875489 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma. Radi DA; Abd-Elazeem MA Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161 [TBL] [Abstract][Full Text] [Related]
11. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients. Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075 [TBL] [Abstract][Full Text] [Related]
12. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747 [TBL] [Abstract][Full Text] [Related]
13. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas? Kandemir NO; Barut F; Bektas S; Ozdamar SO Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902 [TBL] [Abstract][Full Text] [Related]
14. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression. Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871 [TBL] [Abstract][Full Text] [Related]
15. Relationship between high density of peritumoral lymphatic vessels and biological behavior of cervical cancer. En-Lin S; Wei-Wei Y; Xiao-Liang X; Juan X Int J Gynecol Cancer; 2012 Oct; 22(8):1435-41. PubMed ID: 22968518 [TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters. El-Gendi S; Abdel-Hadi M J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565 [TBL] [Abstract][Full Text] [Related]
17. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value. Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149 [TBL] [Abstract][Full Text] [Related]
19. [Lymphatic vessel density in Dukes' B rectal carcinoma and its correlation to prognosis]. Yang X; Li LR; Pan ZZ; Zhou ZW; Wan DS Ai Zheng; 2006 Jun; 25(6):749-52. PubMed ID: 16764774 [TBL] [Abstract][Full Text] [Related]
20. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity. Shareef MM; Radi DM; Eid AM Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]